HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?
The medical technology company reported a notable insider sale as shares returned 35% over the past year.
Overview
Campbell Rogers, Chief Medical Officer at HeartFlow, Inc. (NASDAQ:HTFL), executed a sale of 9,219 shares on August 17, 2026, totaling approximately $380,100 according to the SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price ($41.23); post-transaction value based on August 17, 2026 market close ($41.94).
Details
HeartFlow is a global medical technology company with a market cap of $3.9 billion, operating at scale with 843 employees and generating $212.1 million in trailing 12-month revenue. The company's competitive advantage derives from its proprietary artificial intelligence and computational fluid dynamics algorithms that provide clinically validated, non-invasive coronary artery disease assessment, positioning it as a differentiated player in the cardiac diagnostics market.
Source
Originally published at www.fool.com.